SPS
EBS icon

Susquehanna Portfolio Strategies’s Emergent Biosolutions EBS Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.3M Hold
156,443
– – 0.02% 586
2025
Q4 		$1.93M Hold
156,443
– – 0.03% 510
2025
Q3 		$1.38M Hold
156,443
– – 0.02% 599
2025
Q2 		$998K Buy
156,443
+142,045
+987% +$813K 0.02% 505
2025
Q1 		$70K Buy
+14,398
New +$119K 0.03% 154

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Susquehanna Portfolio Strategies's EBS Position: Q1 2026 in Review

Susquehanna Portfolio Strategies held its Emergent Biosolutions (EBS) position steady in Q1 2026 at 156,443 shares worth $1.3M. The position accounts for 0.02% of the portfolio, ranked #586.

Susquehanna Portfolio Strategies first reported a position in EBS in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.93M in Q4 2025. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • Susquehanna Portfolio Strategies held 156,443 shares of Emergent Biosolutions worth $1.3M as of Q1 2026.
  • Susquehanna Portfolio Strategies left its Emergent Biosolutions share count unchanged in Q1 2026.
  • Emergent Biosolutions made up 0.02% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #586 holding.
  • Susquehanna Portfolio Strategies first reported a position in Emergent Biosolutions in Q1 2025 and has held it in 5 quarters since.
  • Susquehanna Portfolio Strategies's Emergent Biosolutions position peaked at $1.93M in Q4 2025.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.